Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Mary Luz Uribe, Ilaria Marrocco, Yosef Yarden
Cancers (2021) Vol. 13, Iss. 11, pp. 2748-2748
Open Access | Times Cited: 342

Showing 1-25 of 342 citing articles:

Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6677-6677
Open Access | Times Cited: 131
BATMAN-TCM 2.0: an enhanced integrative database for known and predicted interactions between traditional Chinese medicine ingredients and target proteins
Xiangren Kong, Chao Liu, Zuzhen Zhang, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1110-D1120
Open Access | Times Cited: 55
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 51
TGF-β signaling: critical nexus of fibrogenesis and cancer
Anna O. Giarratana, Conor M. Prendergast, Mary Salvatore, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
The Role of Oxidative Stress in Tumorigenesis and Progression
Kexin Li, Zhangyuzi Deng, Chunran Lei, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 441-441
Open Access | Times Cited: 21
Cell migration signaling through EGFR-VAV2-Rac1 pathway is sustained in endosomes
Itziar Pinilla‐Macua, Sachin Surve, Alexander Sorkin
Journal of Cell Science (2025)
Open Access | Times Cited: 2
Decoding the functional impact of the cancer genome through protein–protein interactions
Haian Fu, Xiulei Mo, Andrei A. Ivanov
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
Mário Šereš, Katarina Spacayova, Zdena Sulová, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 248-248
Open Access | Times Cited: 2
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
Youmei Xiao, Zhuoying He, Wanqiong Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Contribution and expression of renal drug transporters in renal cell carcinoma
Yufang Zuo, Tong Li, Shilei Yang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells
Alison Kurimchak, Carlos Herrera-Montávez, Sara Montserrat‐Sangrà, et al.
Science Signaling (2022) Vol. 15, Iss. 749
Open Access | Times Cited: 65
PROTAC therapy as a new targeted therapy for lung cancer
Jennifer W. Li, Guangrong Zheng, Frederic J. Kaye, et al.
Molecular Therapy (2022) Vol. 31, Iss. 3, pp. 647-656
Open Access | Times Cited: 47
On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 33
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
Se Jin Oh, Ji Yeon Lim, Min Kyu Son, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
RSC Advances (2023) Vol. 13, Iss. 27, pp. 18825-18853
Open Access | Times Cited: 24
The effective combination therapies with irinotecan for colorectal cancer
Yun Chai, Jingli Liu, Shuo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 13
Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer
Ashkan Hajjafari, Soheil Sadr, Abbas Rahdar, et al.
Inorganic Chemistry Communications (2024) Vol. 164, pp. 112409-112409
Closed Access | Times Cited: 13
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024)
Debasis Das, Lingzhi Xie, Hong Jian
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 13
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 12
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 12
Recent advances in c-Met-based dual inhibitors in the treatment of cancers
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 11
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 10
Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment
Yingchao Chen, Tao Xiong, Qiang Peng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Therapeutic approaches to enhance natural killer cell cytotoxicity
Terran Stenger, Jeffrey S. Miller
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top